Ultrasound-guided Pulmonary Artery Catheterization in Pulmonary Hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study explores the feasibility of ultrasonography-guided pulmonary artery catheterization (PAC) in patients suspected of having pulmonary hypertension. The goal is to determine if ultrasound guidance can safely and effectively facilitate catheter insertion compared with traditional methods. Eligible adults with suspected PH are referred for diagnostic right heart catheterization, and outcomes related to catheter placement, safety, and feasibility are assessed. No intervention beyond guidance method is described, and the study emphasizes procedural practicality and potential benefits over radiation-based guidance. Results could inform whether ultrasound guidance should be more widely used for PAC in PH evaluation.

Why it matters

Who can join: the full rules

Inclusion Cr### \*\*Inclusion Criteria\*\*

* Adults (≥18 years)
* Clinically suspected PH referred for diagnostic RHC
* Informed consent provided

  \### \*\*Exclusion Criteria\*\*
* Hemodynamic instability requiring immediate intervention
* Poor echocardiographic window despite TTE/TEE
* Contraindications to catheterization
* Known intracardiac shunts or severe tricuspid regurgitation (if it impairs catheter tracking)

iteria: -

Exclusion Criteria:

\-

Where it's running

• Assiut University , Faculty of medicine, Chest Diseases; Pulmonary hypertension UNIT
  Asyut, Select A State, Egypt Recruiting

Study contacts

• Principal investigator: mostafa K Ahmed, MD — Assiut University pulmonary hypertension Unit Chest Department

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levosimendan to see if it helps the heart after PEA in CTEPH

  This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk · NCT07914933

• Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD

  This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.

  Recruiting at 2 sites Early Phase 1 Valley Health System · Paramus, New Jersey and 1 other locations · NCT07837830

• Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

  This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

  Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre · NCT07822997

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Pulmonary Artery Denervation for Pulmonary Hypertension After M-TEER

  This study tests whether PADN can help people with pulmonary hypertension after M-TEER compared with standard medical therapy.

  Recruiting Early Phase 1 Xiamen Cardiovascular Hospital, Xiamen University · Xiamen, Fujian · NCT07662655

• Risk Factor Assessment for Acute Pulmonary Hypertension Crisis

  This study tests how to identify people with pulmonary hypertension who are at risk of a sudden, life-threatening crisis.

  Recruiting at 4 sites Peking Union Medical College Hospital · Guangzhou, Guangdong and 3 other locations · NCT07653958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.